Former Biolase CEO & EVP Launch Technology4Medicine
"While developing the dental laser industry and growing Biolase fromapproximately $1 million to $70 million in sales and 70-80% market share, wegained extensive experience and a deep understanding of the unique clinicaland business needs of the dental community," commented Jones,Technology4Medicine CEO. "Dentists face unique challenges, both clinical andfinancial, and our combined 40 plus years of executive and field experience inthe technology, medical and dental laser markets positions Technology4Medicineand its divisions to help dentists and other medical practitioners to achievetheir goals."
"Over the coming weeks and months Technology4Medicine will be introducinga broad range of advanced technology and laser based products focused onenhancing efficiency, the quality of clinical care, the patient experience andthe bottom line of dental practices," added Bateman, Technology4MedicinePresident.
"Laser therapy has long been established and accepted as standard of careinternationally. Recently the technology and clinical applications have madesignificant breakthroughs and in the U.S. there is a growing acceptance anddemand for laser therapeutic technology to eliminate or dramatically reducepain and accelerate healing. There are many laser therapy applications andindications specific to dentistry that will allow dentists to improve clinicaloutcomes, patient care and ROI."
SOURCE Technology4Medicine, LLC
You May Also Like